EZ-H. pylori Antigen™ – Professional
H. pylori infection
CommercialMarketed for Clinical Lab/POC
Key Facts
About Biomerica
Biomerica is a publicly traded diagnostic company with a mission to improve quality of life through high-performing diagnostic products. It leverages a portfolio of over 100 filed patents and a broad product line across multiple disease areas, including gastrointestinal disorders, diabetes, and endocrinology. The company's strategic vision is to become a leader in diagnostic-guided therapies, particularly for IBS, and it maintains a strong scientific advisory board comprised of leading gastroenterologists. Its business model combines proprietary product development with contract manufacturing services for other pharmaceutical and diagnostic organizations.
View full company profileTherapeutic Areas
Other H. pylori infection Drugs
| Drug | Company | Phase |
|---|---|---|
| GAP ® H. pylori – IgA ELISA | Biomerica | Commercial |
| GAP ® H. pylori – IgG ELISA | Biomerica | Commercial |
| GAP ® H. pylori – IgM ELISA | Biomerica | Commercial |
| HP Detect™ Stool Antigen ELISA | Biomerica | Commercial |
| Talicia | RedHill Biopharma | Approved |